Subscribe to
this category
r

Drug Development

A total of 209 posts are filed under Drug Development
FDA Approves Alynlam’s RNAi Therapeutic for hATTR Amyloidosis
Rare Daily Staff The U.S. Food and Drug Administration approved Alnylam Pharmaceuticals’ Onpattro, a first-of-its-kind RNA interference… Continue Reading
FDA Grants Fast Track Designation to Castle Creek Pharmaceuticals EBS Treatment
Rare Daily Staff The U.S. Food & Drug Administration has granted Fast Track designation to Castle Creek Pharmaceuticals’ CCP-020 for its… Continue Reading
U.S. FDA Grants Fast Track Designation for BioCryst’s HAE Drug
Rare Daily Staff The U.S. Food and Drug Administration granted BioCryst Pharmaceuticals Fast Track designation for BCX7353 for the… Continue Reading
FDA Expands Approval of Vertex CF Drug Orkambi to Include Kids 2 to 5
Rare Daily Staff The U.S. Food and Drug Administration expanded the approved use Vertex Pharmaceuticals’ Orkambi to include children ages… Continue Reading
FDA grants Amryt Pediatric Rare Disease Designation for Experimental Drug to Treat Epidermolysis Bullosa
Rare Daily Staff The U.S. Food and Drug Administration granted Amryt Pharma a Rare Pediatric Disease designation for AP101, the company’s… Continue Reading
FDA Grants Rare Pediatric Disease Designation to Prometic’s Experimental Alsotröm Syndrome Drug
Rare Daily Staff The U.S. Food and Drug Administration has granted Prometic Life Sciences a Rare Pediatric Disease designation for its small… Continue Reading
Partnership Formed to Develop Gene Therapy for Cystic Fibrosis
Rare Daily Staff Oxford BioMedica said it has entered into a process development collaboration agreement with the UK Cystic Fibrosis Gene… Continue Reading
be-a-guest-blogger

Follow us on Twitter